Approval of Cancer Drug Lifts Celgene Stock
Thu, 29 Dec 2005 03:00 AM EST
BLOOMBERG NEWS... Shares of the Celgene Corporation rose 5.9 percent yesterday after regulators approved the company''s Revlimid capsule for a rare blood cancer. ...
|
Approval of Cancer Drug Lifts Celgene Stock - News |
Not Signed In - Sign In / Register
Get Your Free Credit Report Right Now! |
... Shares of the Celgene Corporation rose 5.9 percent yesterday after regulators approved the company''s Revlimid capsule for a rare blood cancer. ... |
Take control over your directory listings...INSTANTLY
Every day, thousands of users find businesses like yours in the GoldBamboo directory.
Limited Time Offer!!!
For only $30 a year, a savings of 70% off our standard rate:
- Edit your listing (whenever you want!)
- Link to your website
- Choose which categories you are listed in
- Describe your services
The process will take only a few minutes and consists of 3 easy steps:
1. Register
>
2. Edit Listings
>
3. Publish
|
GoldBambooTM Your Integrative Health and Wellness Resource November 29, 2009
|
Page Updated: January 17, 2009
|
email this page
print this page
bookmark this page
feedback on this page
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is
provided for educational purposes only. Consult a physician regarding
the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.
Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums
Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.
 |
|
